Natus Medical Incorporated logo
Natus Medical Incorporated NTUS
report update icon

Quarterly report 2022-Q1
added 05-16-2026

Natus Medical Incorporated Financial Statements 2021-2008 | NTUS

Annual Financial Statements Natus Medical Incorporated

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Market Cap

799 M 673 M 1.11 B 1.13 B 1.24 B 1.13 B 1.55 B 1.14 B 675 M 324 M 269 M - - -

Shares

33.7 M 33.6 M 33.7 M 33.1 M 32.6 M 32.5 M 32.3 M 31.5 M 30 M 29 M 28.6 M 28.1 K 27.7 M -

Historical Prices

23.7 20 33 34 38.2 34.8 48 36 22.5 11.2 9.43 - - -

Net Income

13.2 M -16.6 M -15.7 M -22.9 M -20.3 M 42.6 M 37.9 M 32.5 M 23.1 M 3.82 M -11.2 M 11.9 M 11.4 M -

Revenue

473 M 416 M 495 M 531 M 501 M 382 M 376 M 356 M 344 M 292 M 233 M 218 M 166 M -

Cost of Revenue

- - 197 M 218 M 213 M 145 M 145 M 138 M 139 M 129 M 102 M 88.6 M 66.1 M -

Gross Profit

274 M 217 M 292 M 304 M 281 M 235 M 228 M 214 M 202 M 163 M 131 M 130 M 100 M -

Operating Income

23.8 M -20.2 M -15.7 M -24.6 M 8.72 M 55.3 M 53.5 M 45.9 M 34.7 M 5.11 M -10.3 M 17.9 M 15.3 M -

Interest Expense

1.87 M 3.66 M 4.94 M 6.79 M 5.08 M 430 K 352 K 438 K 1.68 M 489 K 268 K 128 K - -

EBITDA

51.9 M 7.92 M 15.1 M 9.3 M 38.8 M 72.1 M 69.5 M 57.6 M 47.5 M 17.7 M -141 K 27 M 23.2 M -

Operating Expenses

250 M 237 M 307 M 329 M 272 M 180 M 174 M 169 M 168 M 158 M 142 M 112 M 85 M -

General and Administrative Expenses

52.8 M 49.1 M 59.6 M 70.6 M 74.4 M 50.9 M 46.4 M 45.4 M 43.4 M 51 M 33 M 35.8 M 23 M -

All numbers in USD currency

Quarterly Income Statement Natus Medical Incorporated

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - 34.1 M 34.2 M 33.6 M 33.6 M 33.6 M 33.9 M 33.8 M 33.8 M 33.8 M 34.1 M 33.7 M 33.6 M 33.6 M 33.8 M 33.3 M 32.9 M 32.8 M 33.1 M 32.6 M 32.5 M 32.5 M 32.9 M 32.4 M 32.4 M 32.6 M 33.2 M 32.4 M 32.3 M 32.1 M 32.6 M 31.6 M 31.4 M 31.1 M 31.4 M 30.1 M 29.7 K 29.6 K 30.1 M 29.1 K 28.9 K 28.9 M 29.4 M 28.6 M 28.4 M 28.3 M

Net Income

- - - 1.9 M - 5.57 M 3.46 M 2.4 M - -9.32 M -8.9 M -3.6 M - 8.46 M 4.19 M -30 M - -5.58 M -2.58 M -3.15 M - -8.51 M -5.03 M 348 K - 13.3 M 10.5 M 8.54 M - 10.9 M 9.85 M 8.6 M - 7.79 M 7.74 M 6.25 M - 6.29 M 4.02 M 3.44 M - -1.95 M 445 K 358 K - 154 K 2.36 M 3.1 M

Revenue

- - - 120 M - 114 M 116 M 115 M - 103 M 84.8 M 109 M - 123 M 126 M 115 M - 131 M 131 M 129 M - 123 M 122 M 125 M - 90.9 M 96 M 87.3 M - 94.6 M 91.9 M 89.4 M - 89.9 M 86.3 M 85.6 M - 85.4 M 82.2 M 85.8 M - 80.7 M 61 M 59.5 M - 51.3 M 58.1 M 59.1 M

Cost of Revenue

- - - - - - - - - - - - - 48.7 M 52.2 M 46.4 M - 51.6 M 52.9 M 55.4 M - 47.1 M 54.6 M 56.9 M - 32.2 M 37.9 M 32.5 M - 35.5 M 33.8 M 35.1 M - 34.3 M 35.3 M 35.7 M - 34.1 M 33.9 M 36.6 M - 36.5 M 26.8 M 26 M - 23.8 M 25 M 24.4 M

Gross Profit

- - - 65.4 M - 67.7 M 66.4 M 66.5 M - 47.5 M 40.6 M 62.8 M - 73 M 71.6 M 66.6 M - 77.1 M 75 M 71.7 M - 74.2 M 66.1 M 66.7 M - 58.1 M 57.5 M 54.3 M - 58.4 M 57.4 M 53.6 M - 55.5 M 51 M 49.9 M - 51.3 M 48.4 M 49.2 M - 44.3 M 34.2 M 33.5 M - 27.6 M 33.1 M 34.7 M

Operating Income

- - - 4.18 M - 8.54 M 6.01 M 4.52 M - -9.94 M -12 M -3.23 M - 8.09 M 7.5 M -37.6 M - -2.91 M -3.79 M -2.73 M - 8.54 M -6.28 M 1.4 M - 15.2 M 13.9 M 11.2 M - 16.1 M 14 M 13.3 M - 12.8 M 10.3 M 8.68 M - 9.14 M 6.16 M 4.86 M - -4.85 M 805 K 161 K - -1.04 M 3.16 M 5.04 M

Interest Expense

- - - 267 K - 332 K 556 K 766 K - 1.11 M 976 K 717 K - 1.17 M 1.47 M 1.53 M - 1.65 M 1.64 M 1.96 M - 1.04 M 1.28 M 980 K - 223 K 97 K 31 K - - - 1 K - 104 K 120 K 264 K - 138 K 469 K 477 K - 215 K 8 K 8 K - 47 K 64 K -

EBITDA

- - - 10.9 M - 29.9 M 20.5 M 11.8 M - 11.1 M 1.64 M 3.76 M - 31 M 22.9 M -29.9 M - 22.7 M 12.9 M 5.19 M - 29.4 M 7.54 M 8.15 M - 28.1 M 22.3 M 15.4 M - 27.4 M 21.2 M 16.3 M - 21.3 M 15.9 M 12 M - 18.7 M 12.5 M 7.99 M - -3.85 M 2.1 M 3.1 M - 5.73 M 7.65 M 7.59 M

Operating Expenses

- - - 61.2 M - 59.2 M 60.4 M 62 M - 57.5 M 52.6 M 66 M - 64.9 M 64.1 M 104 M - 80 M 78.8 M 74.4 M - 65.7 M 72.4 M 65.3 M - 42.9 M 43.5 M 43 M - 42.3 M 43.4 M 40.3 M - 42.8 M 40.7 M 41.2 M - 42.2 M 42.2 M 44.4 M - 49.1 M 33.4 M 33.3 M - 28.6 M 29.9 M 29.7 M

General and Administrative Expenses

- - - 12.8 M - 12.9 M 12.6 M 14.9 M - 12.4 M 11.2 M 13.2 M - 15.1 M 12.7 M 16.3 M - 15.8 M 23.7 M 17.4 M - 17.3 M 24.2 M 16 M - 12.8 M 11.9 M 12.5 M - 10 M 11.7 M 11.6 M - 14.7 M 10.8 M 12.3 M - 14.3 M 11.8 M 14 M - 18.8 M 10.9 M 9.53 M - 7.81 M 7.99 M 9.03 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Natus Medical Incorporated NTUS
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Natus Medical Incorporated plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 64.0 7.26 % $ 9.72 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 44.68 0.06 % $ 66.1 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.7 0.06 % $ 634 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.61 13.03 % $ 414 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 45.18 3.31 % $ 1.4 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.3 1.63 % $ 268 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 16.08 0.75 % $ 576 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Electromed Electromed
ELMD
$ 27.86 1.05 % $ 230 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 65.58 3.69 % $ 1.94 B costa-ricaCosta-rica
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 85.73 0.32 % $ 50.1 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 5.57 0.43 % $ 753 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.9 0.69 % $ 63.9 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 15.88 2.25 % $ 1.22 B usaUSA
Inogen Inogen
INGN
$ 5.23 2.75 % $ 139 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.19 0.21 % $ 917 M israelIsrael
Inspire Medical Systems Inspire Medical Systems
INSP
$ 68.81 0.59 % $ 2.02 B usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.63 2.51 % $ 10.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 85.2 0.08 % $ 1.08 B usaUSA
AxoGen AxoGen
AXGN
$ 43.32 0.48 % $ 1.99 B usaUSA
Align Technology Align Technology
ALGN
$ 145.63 4.36 % $ 10.6 B usaUSA
LENSAR LENSAR
LNSR
$ 7.08 0.28 % $ 84.7 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 88.51 0.32 % $ 113 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.71 0.1 % $ 696 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
Myomo Myomo
MYO
$ 1.67 1.83 % $ 69.9 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.66 0.45 % $ 42.8 M israelIsrael
InspireMD InspireMD
NSPR
$ 0.7 0.37 % $ 45 M israelIsrael
Orthofix Medical Orthofix Medical
OFIX
$ 9.16 0.11 % $ 363 M curacaoCuracao
Outset Medical Outset Medical
OM
$ 3.13 1.29 % $ 47.6 K usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 135.78 0.01 % $ 9.55 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.6 1.66 % $ 169 M canadaCanada
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.18 0.63 % $ 136 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 11.58 5.75 % $ 323 M australiaAustralia
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.83 1.37 % $ 116 M usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 1.87 5.06 % $ 5.19 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.22 0.4 % $ 27 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 26.68 0.02 % $ 23.1 B britainBritain
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA